The article lists nausea, vomiting, diarrhoea, and pancreatitis risk as known side effects, and says people with a personal or family history of medullary thyroid cancer should avoid GLP-1 therapy
Some patients are looking for more aggressive appetite suppression and weight loss support
Other manufacturers began synthesizing GLP-1 analogs with altered DPP-4 binding sites that bypassed degradation and remained in the body for weeks at a time [26]
A Safe, High-Level Microdosing Guide If you and your clinician decide to explore microdosing glp 1 medications, the process usually looks more like a framework than a rigid script: Assessment first: detailed medical history, medication list, family history (especially thyroid cancers), and baseline labs
Acute pancreatitis is a recognised but uncommon risk
Can these compounds be used in combination research